Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure.
Gadolinium based MRI contrast agents are considered very safe due to their well known pharmacologic properties and elimination mechanisms. In this paper, we present a unique case in whom transient enhancement of CSF with contrast is seen. Severe renal failure is demonstrated to be responsible for this finding. The diagnostic criteria for everyday clinical setting and possible clinical implications are discussed.
Erbay
S H
SH
Department of Radiology, New England Medical Center Hospitals and Tufts University School of Medicine, Boston, Massachusetts 02111, USA. serbay@lifespan.org
Bhadelia
R A
RA
D000368:Aged; D003287:Contrast Media; D005260:Female; D005682:Gadolinium; D006801:Humans; D007676:Kidney Failure, Chronic / Q000134:cerebrospinal fluid* / Q000473:pathology*; D008279:Magnetic Resonance Imaging
D003287:Contrast Media; D005682:Gadolinium